4.6 Review

Current management and future challenges in salivary glands cancer

Related references

Note: Only part of the references are listed.
Article Oncology

Phase II Clinical Trial of Axitinib and Avelumab in Patients With Recurrent/Metastatic Adenoid Cystic Carcinoma

Renata Ferrarotto et al.

Summary: We conducted a phase II trial to evaluate the efficacy of VEGFR inhibitor axitinib and PD-L1 inhibitor avelumab in patients with recurrent/metastatic adenoid cystic carcinoma (R/M ACC). The study achieved its primary endpoint with a confirmed objective response rate (ORR) of 18%. The potential benefit of avelumab in addition to axitinib in ACC warrants further investigation.

JOURNAL OF CLINICAL ONCOLOGY (2023)

Article Biochemistry & Molecular Biology

Nivolumab plus ipilimumab in advanced salivary gland cancer: a phase 2 trial

Joris L. Vos et al.

NATURE MEDICINE (2023)

Article Genetics & Heredity

Clinicopathological investigation of secretory carcinoma cases including a successful treatment outcome using entrectinib for high-grade transformation: a case report

Kensuke Suzuki et al.

Summary: This study investigated the clinical, pathological, and molecular genetic characteristics of low-grade and high-grade components of salivary gland secretory carcinoma (SC). High-grade transformed SC showed aggressive clinical and pathological features, and the presence of ETV6-NTRK3 translocation may represent a therapeutic target for this type of SC.

BMC MEDICAL GENOMICS (2022)

Review Radiology, Nuclear Medicine & Medical Imaging

Ultrasound-guided core biopsy in the diagnosis of parotid neoplasia: an overview and update with a review of the literature

Katharine Julia Hurry et al.

Summary: This review provides an update on the current practice and outcomes of parotid tissue sampling techniques, with a focus on ultrasound-guided core biopsy (USCB) and fine needle aspiration cytology (FNAC). The results show that USCB has higher sensitivity and specificity, particularly in the detection of malignant tumors. Complications following USCB are rare, and there is minimal variation in results between institutions using this technique.

BRITISH JOURNAL OF RADIOLOGY (2022)

Article Otorhinolaryngology

Resection of the internal carotid artery in selected patients affected by cancer of the skull base

Marco Ferrari et al.

Summary: In this study, ten patients with skull base cancer underwent surgery that included resection of the internal carotid artery. The results showed that in adequately selected patients, resection of the internal carotid artery is feasible and survival outcomes are acceptable.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2022)

Article Otorhinolaryngology

Evaluation of Surgical Margin Status in Patients With Salivary Gland Cancer

Martin Hanson et al.

Summary: This cohort study found that patients with salivary gland cancer with positive or dose surgical margins were at increased risk for poorer local control and survival. However, after controlling for tumor stage, histologic risk group, and the use of adjuvant radiotherapy, margin status was not independently associated with poorer outcome. Subgroup analyses suggest that patients with close margins and low or intermediate-risk histologic type with stage I/II cancers may not require adjuvant radiotherapy.

JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY (2022)

Article Otorhinolaryngology

National Analysis of Oropharyngeal Salivary Gland Malignancies Treated With Transoral Robotic Surgery

Craig A. Bollig et al.

Summary: This study analyzed 785 patients with OPSGMs and found that non-soft palate primary site and treatment at an academic facility were independently associated with TORS. There were no significant differences in positive margin rate, 30-day mortality, or overall survival between TORS and nonrobotic resections, but the 30-day unplanned readmission rate was higher in the TORS group.

OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2022)

Article Oncology

Larotrectinib Treatment for Patients With TRK Fusion-Positive Salivary Gland Cancers

Xiuning Le et al.

Summary: This article investigates the efficacy and safety of larotrectinib in patients with TRK fusion-positive salivary gland cancers. The results demonstrate that larotrectinib has robust and durable efficacy in treating different histologies of salivary gland tumors, with minimal side effects. These findings emphasize the importance of testing salivary gland cancer for NTRK gene fusions.

ONCOLOGIST (2022)

Review Oncology

The European Particle Therapy Network (EPTN) consensus on the follow-up of adult patients with brain and skull base tumours treated with photon or proton irradiation

Laurien De Roeck et al.

Summary: The purpose of this study is to develop recommendations for uniform follow-up and toxicity scoring of adult brain tumour patients treated with radiotherapy. A consensus was reached among radiation-oncology experts using the Delphi method, resulting in a basic framework for consistent toxicity scoring and follow-up. These recommendations will enable the collection of uniform toxicity data and facilitate collaboration in the research field of radiation-induced toxicities.

RADIOTHERAPY AND ONCOLOGY (2022)

Article Oncology

Evaluation of pembrolizumab monotherapy in patients with previously treated advanced salivary gland carcinoma in the phase 2 KEYNOTE-158 study

Caroline Even et al.

Summary: In this study, we evaluated pembrolizumab monotherapy for patients with advanced salivary gland carcinoma. The results showed that a subset of patients responded positively to the treatment, with a duration of response exceeding 2 years. The safety profile of pembrolizumab was manageable.

EUROPEAN JOURNAL OF CANCER (2022)

Review Oncology

Salivary gland cancers in elderly patients: challenges and therapeutic strategies

Elena Colombo et al.

Summary: This article discusses the most common histological diagnoses of salivary gland carcinomas in the elderly population and the corresponding survival outcomes. It also reviews the current therapeutic strategies for locoregionally advanced and metastatic disease, considering the recent advances in precision oncology. The collaboration between the Multidisciplinary Tumor Board and the Geriatrician aims to determine the most appropriate treatment pathway for each elderly patient, focusing on overall functionality rather than chronological age.

FRONTIERS IN ONCOLOGY (2022)

Article Oncology

Role of Intraparotid and Neck Lymph Node Metastasis in Primary Parotid Cancer Surgery: A Population-Based Analysis

Mussab Kouka et al.

Summary: This study investigated the prognostic role of intraparotid and cervical lymph node metastasis in primary parotid cancer and found that LODDS-PAR was the only independent predictor of overall survival.

CANCERS (2022)

Review Oncology

Systemic therapy for salivary gland malignancy: current status and future perspectives

Yoshinori Imamura et al.

Summary: Salivary gland malignancies are rare tumors with diverse histological and biological features. The application of systemic therapy in the treatment of salivary gland malignancies remains challenging, and there is currently no defined treatment advantage. Personalized therapies have been widely accepted, but a multidisciplinary approach is necessary to consider both patient needs and tumor characteristics.

JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2022)

Article Pathology

Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Salivary Glands

Alena Skalova et al.

Summary: The salivary gland section in the 5th edition of the World Health Organization Classification of Head and Neck Tumours introduces several new tumor entities and emphasizes the reduction of non-relevant tumors. It also highlights the significance of defining molecular alterations in salivary gland tumors for diagnostic purposes.

HEAD & NECK PATHOLOGY (2022)

Article Medical Laboratory Technology

Reevaluation of Salivary Lymphadenoma A Subgroup Identified as Warthin-like Mucoepidermoid Carcinoma Following Molecular Investigation for MAML2 Rearrangement

Chunye Zhang et al.

Summary: The study found that Warthin-like MEC and LAD share overlapping clinicopathologic features, and accurate differentiation requires careful histologic evaluation and detection of MAML2 rearrangement.

ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2021)

Review Radiology, Nuclear Medicine & Medical Imaging

Multiparametric magnetic resonance imaging of parotid tumors: A systematic review

H. Coudert et al.

Summary: This systematic review provides an overview of the contribution of multiparametric MRI in the diagnosis of parotid tumors, highlighting the use of DWI and DCE imaging, as well as the differences in morphological signs between benign and malignant tumors. The combination of different imaging modalities can significantly increase the diagnostic accuracy of MRI for focal parotid tumors.

DIAGNOSTIC AND INTERVENTIONAL IMAGING (2021)

Article Oncology

Newly Identified Members of FGFR1 Splice Variants Engage in Cross-talk with AXL/AKT Axis in Salivary Adenoid Cystic Carcinoma

Joseph O. Humtsoe et al.

Summary: This study identifies several FGFR1 variants that function through the AXL/AKT signaling pathway independent of FGF/FGFR1, desensitizing cells to FGFR1 inhibitor, suggestive of a potential resistance mechanism in ACC.

CANCER RESEARCH (2021)

Article Oncology

Abiraterone Acetate in Patients With Castration-Resistant, Androgen Receptor-Expressing Salivary Gland Cancer: A Phase II Trial

Laura D. Locati et al.

Summary: Abiraterone acetate plus luteinizing hormone-releasing hormone agonist is effective and safe as a second-line option in AR-expressing, castration-resistant salivary gland carcinomas, with an overall response rate of 21% and disease control rate of 62.5%, showing no significant correlation with the activity of ADT.

JOURNAL OF CLINICAL ONCOLOGY (2021)

Review Pathology

High-grade Transformation/Dedifferentiation in Salivary Gland Carcinomas: Occurrence Across Subtypes and Clinical Significance

Alena Skalova et al.

Summary: High-grade transformation in salivary gland carcinomas consists of traditional low-grade components intermingled with areas of high-grade morphology, with higher Ki-67 labeling index and potential genetic alterations like p53 inactivation and HER2 overexpression. These tumors are more aggressive than conventional carcinomas, with a higher recurrence rate and poorer prognosis, necessitating thorough sampling to avoid overlooking the high-grade component.

ADVANCES IN ANATOMIC PATHOLOGY (2021)

Article Otorhinolaryngology

Prognostic scoring models in parotid gland carcinoma

Marie Westergaard-Nielsen et al.

Summary: This study identified prognostic factors for recurrence in patients with parotid gland carcinoma and tested three prognostic scoring models. Factors such as age, histology grade, tumor stage, lymph node metastases, and margin involvement were associated with reduced recurrence-free survival. The model with the highest concordance with actual outcomes had a C-index of 0.76.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2021)

Article Oncology

Management of Salivary Gland Malignancy: ASCO Guideline

Jessica L. Geiger et al.

Summary: This guideline provides evidence-based recommendations for the management of salivary gland malignancy, addressing diagnosis, treatment, and follow-up strategies based on a comprehensive review of relevant studies.

JOURNAL OF CLINICAL ONCOLOGY (2021)

Article Pathology

Microsecretory Adenocarcinoma of Salivary Glands: An Expanded Series of 24 Cases

Justin A. Bishop et al.

Summary: Microsecretory adenocarcinoma (MSA) is a recently described salivary gland tumor with characteristic histologic and immunophenotypic features. Most cases of MSA occur in the oral cavity, with consistent clinical behavior following surgery. The study suggests that MSA is a distinct and low-grade salivary gland carcinoma that generally has a benign clinical course.

HEAD & NECK PATHOLOGY (2021)

Article Pathology

Trophoblast Cell Surface Antigen 2 (Trop-2) Protein is Highly Expressed in Salivary Gland Carcinomas and Represents a Potential Therapeutic Target

Philipp Wolber et al.

Summary: This study found that various types of salivary gland carcinomas (SGCs) express Trop-2 at different levels, suggesting its potential as a therapeutic target for further clinical studies. Trop-2 may represent a promising avenue for the treatment of advanced SGCs, for which there are currently limited systemic treatment options.

HEAD & NECK PATHOLOGY (2021)

Article Oncology

Proteogenomic Analysis of Salivary Adenoid Cystic Carcinomas Defines Molecular Subtypes and Identifies Therapeutic Targets

Renata Ferrarotto et al.

Summary: Salivary gland adenoid cystic carcinoma (ACC) exhibits heterogeneous clinical behavior and can be classified into two molecular subtypes: ACC-I and ACC-II. ACC-I is characterized by poor prognosis, upregulation of MYC and NOTCH mutations, while ACC-II shows less aggressive clinical course with upregulation of TP63 and receptor tyrosine kinases.

CLINICAL CANCER RESEARCH (2021)

Review Oncology

Rate of Occult Neck Nodal Metastasis in Parotid Cancer: A Meta-Analysis

Anton Warshavsky et al.

Summary: The rate of occult neck nodal metastasis in parotid malignancies is low, with neck level 2 being the most commonly involved. This meta-analysis did not provide conclusive evidence on the appropriate extent of elective neck dissection in parotid cancer.

ANNALS OF SURGICAL ONCOLOGY (2021)

Review Otorhinolaryngology

Prognostic role of intraparotid lymph node metastasis in primary parotid cancer: Systematic review

Orlando Guntinas-Lichius et al.

Summary: This study examined the prognostic importance of intraparotid lymph node metastasis (P+) in patients with primary parotid gland carcinoma. The results indicated that P+ is an independent negative prognostic factor in primary parotid gland cancer and should be considered in treatment planning.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2021)

Review Oncology

Salivary Gland Carcinoma: Novel Targets to Overcome Treatment Resistance in Advanced Disease

Larissa Di Villeneuve et al.

FRONTIERS IN ONCOLOGY (2020)

Review Pharmacology & Pharmacy

Genomics in non-adenoid cystic group of salivary gland cancers: one or more druggable entities?

Stefano Cavalieri et al.

EXPERT OPINION ON INVESTIGATIONAL DRUGS (2019)

Article Otorhinolaryngology

Androgen deprivation therapy for androgen receptor-positive advanced salivary duct carcinoma: A nationwide case series of 35 patients in The Netherlands

Eline Boon et al.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2018)

Article Oncology

Pembrolizumab for the Treatment of Advanced Salivary Gland Carcinoma Findings of the Phase 1b KEYNOTE-028 Study

Roger B. Cohen et al.

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2018)

Article Pathology

Recurrent RET Gene Rearrangements in Intraductal Carcinomas of Salivary Gland

Ilan Weinreb et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2018)

Review Radiology, Nuclear Medicine & Medical Imaging

Diagnostic accuracy of magnetic resonance imaging techniques for parotid tumors, a systematic review and meta-analysis

Ying-Ying Liang et al.

CLINICAL IMAGING (2018)

Article Otorhinolaryngology

Close Margins and Adjuvant Radiotherapy in Acinic Cell Carcinoma of the Parotid Gland

Joseph Zenga et al.

JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY (2018)

Article Oncology

Concurrent Chemoradiotherapy in the Adjuvant Treatment of High-risk Primary Salivary Gland Malignancies

Brian J. Gebhardt et al.

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2018)

Article Otorhinolaryngology

Primary parotid carcinoma: analysis of risk factors and validation of a prognostic index

Alberto Paderno et al.

EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2018)

Editorial Material Otorhinolaryngology

Preoperative diagnostic of parotid gland neoplasms: fine-needle aspiration cytology or core needle biopsy?

Peter Zbaren et al.

EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2018)

Editorial Material Otorhinolaryngology

Deep lobe parotidectomy-why, when, and how?

Kerry D. Olsen et al.

EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2017)

Article Otorhinolaryngology

Defining the surgical margins of adenoid cystic carcinoma and their impact on outcome: An international collaborative study

Moran Amit et al.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2017)

Article Oncology

Surgical treatment of salivary malignant tumors

Davide Lombardi et al.

ORAL ONCOLOGY (2017)

Editorial Material Oncology

Taking it up a NOTCH: a novel subgroup of ACC is identified

Renata Ferrarotto et al.

ONCOTARGET (2017)

Review Radiology, Nuclear Medicine & Medical Imaging

Contrast-enhanced ultrasound in the evaluation of parotid gland lesions: an update of the literature

E. David et al.

ULTRASOUND (2016)

Article Oncology

Patterns and treatment of neck metastases in patients with salivary gland cancers

Shin-Hyuk Yoo et al.

JOURNAL OF SURGICAL ONCOLOGY (2015)

Article Otorhinolaryngology

Proton therapy for head and neck adenoid cystic carcinoma: Initial clinical outcomes

Okechukwu R. Linton et al.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2015)

Article Otorhinolaryngology

International collaborative validation of intraneural invasion as a prognostic marker in adenoid cystic carcinoma of the head and neck

Moran Amit et al.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2015)

Article Otorhinolaryngology

MRI criteria for the diagnosis of pleomorphic adenoma: a validation study

Soroush Zaghi et al.

AMERICAN JOURNAL OF OTOLARYNGOLOGY (2014)

Article Oncology

Treatment of the Neck in Carcinoma of the Parotid Gland

Safina Ali et al.

ANNALS OF SURGICAL ONCOLOGY (2014)

Article Otorhinolaryngology

Deep lobe parotidectomy: clinical rationale in the management of primary and metastatic cancer

Kerry D. Olsen et al.

EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2014)

Article Otorhinolaryngology

Elective neck management for high-grade salivary gland carcinoma

Michael P. Herman et al.

AMERICAN JOURNAL OF OTOLARYNGOLOGY (2013)

Article Neurosciences

Pitfalls in the Staging of Cancer of the Major Salivary Gland Neoplasms

Elliott R. Friedman et al.

NEUROIMAGING CLINICS OF NORTH AMERICA (2013)

Article Oncology

Trastuzumab for the Treatment of Salivary Duct Carcinoma

Sewanti A. Limaye et al.

ONCOLOGIST (2013)

Article Otorhinolaryngology

Salvage Surgery for Recurrent Cancers of the Oropharynx Comparing TORS With Standard Open Surgical Approaches

Hilliary White et al.

JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY (2013)

Article Otorhinolaryngology

ANATOMIC DISTRIBUTION OF CERVICAL LYMPH NODE SPREAD IN PAROTID CARCINOMA

Edward J. Chisholm et al.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2011)

Article Otorhinolaryngology

PRIMARY CANCER OF THE SPHENOID SINUS-A GETTEC STUDY

Pierre Olivier Vedrine et al.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2009)

Article Otorhinolaryngology

Proton beam radiation therapy for skull base adenoid cystic carcinoma

Pascal Pommier et al.

ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY (2006)

Review Oncology

Systemic therapy in the palliative management of advanced salivary gland cancers

Scott A. Laurie et al.

JOURNAL OF CLINICAL ONCOLOGY (2006)

Article Otorhinolaryngology

Radiotherapy alone or combined with surgery for adenoid cystic carcinoma of the head and neck

WM Mendenhall et al.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2004)

Article Otorhinolaryngology

Outcome of curative management of malignant tumours of the parotid gland

P Kirkbride et al.

JOURNAL OF OTOLARYNGOLOGY (2001)